Lee S, Duncan K A, Chou H, Chen D, Kohli K, Huang C F, Stallcup M R
Department of Pathology, University of Southern California Health Sciences Campus, Los Angeles 90033, USA.
Mol Endocrinol. 1995 Jul;9(7):826-37. doi: 10.1210/mend.9.7.7476966.
Mouse T lymphoma cell line W7MG1, which is killed by physiological concentrations of glucocorticoid agonists, was used as a convenient genetic system for isolating sublines containing mutant glucocorticoid receptors (GR) with hormone-binding deficiencies. Partially hormone-resistant cell clones were derived from chemically mutagenized cell populations by selecting for growth in moderate concentrations of dexamethasone (Dex) and then screening for failure to grow in high Dex concentrations. Such clones are likely to have mutant GR. In GR cDNA clones from the partially resistant cell sublines, three different functionally significant mutations in the hormone-binding domain were identified: Leu-569 changed to Phe (L569F), Leu-670 to Phe (L670F), and Met-672 to Ile (M672I). Dose-response analyses with Dex and affinity labeling studies with dexamethasone 21-mesylate in transiently transfected cells indicated that all three mutant GR species had hormone-binding deficiencies. However, at saturating Dex concentrations the mutant and wild type GR activated a hormone-inducible reporter gene to the same extent; thus, these three mutations did not affect the ability of GR to activate transcription of the reporter gene after hormone was bound. In dose-response curves conducted with several glucocorticoid agonists, mutations L670F and M672I caused no change in ligand-binding specificities, while mutation L569F caused a modest change in specificity. Quantitative hormone-binding studies conducted with mutant GR synthesized in cell-free reactions showed that mutant GR species L569F and M672I had reduced Dex-binding affinities both at 0 C and at 22 C in the presence of molybdate. In contrast, for the L670F mutant, which exhibited the severest deficiency in vivo, the hormone-binding deficiency in the cell-free system was evident only at 26-37 C and primarily in the absence of molybdate. We propose that the L670F GR is an activation-labile type of mutant, which binds hormone normally in the presence of heat shock protein 90 but loses hormone rapidly after dissociation from heat shock protein 90. These three mutations define two new subregions of the GR polypeptide that are important for hormone binding.
小鼠T淋巴瘤细胞系W7MG1可被生理浓度的糖皮质激素激动剂杀死,它被用作一种便捷的遗传系统,用于分离含有具有激素结合缺陷的突变糖皮质激素受体(GR)的亚系。通过选择在中等浓度地塞米松(Dex)中生长,然后筛选在高浓度Dex中不能生长的细胞,从化学诱变的细胞群体中获得部分激素抗性细胞克隆。这样的克隆可能具有突变的GR。在来自部分抗性细胞亚系的GR cDNA克隆中,在激素结合结构域中鉴定出三个不同的功能上重要的突变:Leu-569变为Phe(L569F),Leu-670变为Phe(L670F),以及Met-672变为Ile(M672I)。用Dex进行的剂量反应分析以及在瞬时转染细胞中用地塞米松21-甲磺酸盐进行的亲和标记研究表明,所有三种突变GR都有激素结合缺陷。然而,在饱和Dex浓度下,突变型和野生型GR激活激素诱导型报告基因的程度相同;因此,这三个突变不影响GR在结合激素后激活报告基因转录的能力。在用几种糖皮质激素激动剂进行的剂量反应曲线中,L670F和M672I突变不引起配体结合特异性的变化,而L569F突变引起特异性的适度变化。用无细胞反应中合成的突变GR进行的定量激素结合研究表明,在0℃和22℃下,在钼酸盐存在的情况下,突变GR种类L569F和M672I的Dex结合亲和力降低。相比之下,对于在体内表现出最严重缺陷的L670F突变体,无细胞系统中的激素结合缺陷仅在26-37℃时明显,并且主要是在没有钼酸盐的情况下。我们提出,L670F GR是一种激活不稳定型突变体,它在热休克蛋白90存在下正常结合激素,但在与热休克蛋白90解离后迅速失去激素。这三个突变定义了GR多肽中对激素结合很重要的两个新亚区域。